Cargando…

Resistant starch can improve insulin sensitivity independently of the gut microbiota

BACKGROUND: Obesity-related diseases, including type 2 diabetes and cardiovascular disease, have reached epidemic proportions in industrialized nations, and dietary interventions for their prevention are therefore important. Resistant starches (RS) improve insulin sensitivity in clinical trials, but...

Descripción completa

Detalles Bibliográficos
Autores principales: Bindels, Laure B., Segura Munoz, Rafael R., Gomes-Neto, João Carlos, Mutemberezi, Valentin, Martínez, Inés, Salazar, Nuria, Cody, Elizabeth A., Quintero-Villegas, Maria I., Kittana, Hatem, de los Reyes-Gavilán, Clara G, Schmaltz, Robert J., Muccioli, Giulio G., Walter, Jens, Ramer-Tait, Amanda E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294823/
https://www.ncbi.nlm.nih.gov/pubmed/28166818
http://dx.doi.org/10.1186/s40168-017-0230-5
_version_ 1782505313039024128
author Bindels, Laure B.
Segura Munoz, Rafael R.
Gomes-Neto, João Carlos
Mutemberezi, Valentin
Martínez, Inés
Salazar, Nuria
Cody, Elizabeth A.
Quintero-Villegas, Maria I.
Kittana, Hatem
de los Reyes-Gavilán, Clara G
Schmaltz, Robert J.
Muccioli, Giulio G.
Walter, Jens
Ramer-Tait, Amanda E.
author_facet Bindels, Laure B.
Segura Munoz, Rafael R.
Gomes-Neto, João Carlos
Mutemberezi, Valentin
Martínez, Inés
Salazar, Nuria
Cody, Elizabeth A.
Quintero-Villegas, Maria I.
Kittana, Hatem
de los Reyes-Gavilán, Clara G
Schmaltz, Robert J.
Muccioli, Giulio G.
Walter, Jens
Ramer-Tait, Amanda E.
author_sort Bindels, Laure B.
collection PubMed
description BACKGROUND: Obesity-related diseases, including type 2 diabetes and cardiovascular disease, have reached epidemic proportions in industrialized nations, and dietary interventions for their prevention are therefore important. Resistant starches (RS) improve insulin sensitivity in clinical trials, but the mechanisms underlying this health benefit remain poorly understood. Because RS fermentation by the gut microbiota results in the formation of physiologically active metabolites, we chose to specifically determine the role of the gut microbiota in mediating the metabolic benefits of RS. To achieve this goal, we determined the effects of RS when added to a Western diet on host metabolism in mice with and without a microbiota. RESULTS: RS feeding of conventionalized mice improved insulin sensitivity and redressed some of the Western diet-induced changes in microbiome composition. However, parallel experiments in germ-free littermates revealed that RS-mediated improvements in insulin levels also occurred in the absence of a microbiota. RS reduced gene expression of adipose tissue macrophage markers and altered cecal concentrations of several bile acids in both germ-free and conventionalized mice; these effects were strongly correlated with the metabolic benefits, providing a potential microbiota-independent mechanism to explain the physiological effects of RS. CONCLUSIONS: This study demonstrated that some metabolic benefits exerted by dietary RS, especially improvements in insulin levels, occur independently of the microbiota and could involve alterations in the bile acid cycle and adipose tissue immune modulation. This work also sets a precedent for future mechanistic studies aimed at establishing the causative role of the gut microbiota in mediating the benefits of bioactive compounds and functional foods. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40168-017-0230-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5294823
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52948232017-02-09 Resistant starch can improve insulin sensitivity independently of the gut microbiota Bindels, Laure B. Segura Munoz, Rafael R. Gomes-Neto, João Carlos Mutemberezi, Valentin Martínez, Inés Salazar, Nuria Cody, Elizabeth A. Quintero-Villegas, Maria I. Kittana, Hatem de los Reyes-Gavilán, Clara G Schmaltz, Robert J. Muccioli, Giulio G. Walter, Jens Ramer-Tait, Amanda E. Microbiome Research BACKGROUND: Obesity-related diseases, including type 2 diabetes and cardiovascular disease, have reached epidemic proportions in industrialized nations, and dietary interventions for their prevention are therefore important. Resistant starches (RS) improve insulin sensitivity in clinical trials, but the mechanisms underlying this health benefit remain poorly understood. Because RS fermentation by the gut microbiota results in the formation of physiologically active metabolites, we chose to specifically determine the role of the gut microbiota in mediating the metabolic benefits of RS. To achieve this goal, we determined the effects of RS when added to a Western diet on host metabolism in mice with and without a microbiota. RESULTS: RS feeding of conventionalized mice improved insulin sensitivity and redressed some of the Western diet-induced changes in microbiome composition. However, parallel experiments in germ-free littermates revealed that RS-mediated improvements in insulin levels also occurred in the absence of a microbiota. RS reduced gene expression of adipose tissue macrophage markers and altered cecal concentrations of several bile acids in both germ-free and conventionalized mice; these effects were strongly correlated with the metabolic benefits, providing a potential microbiota-independent mechanism to explain the physiological effects of RS. CONCLUSIONS: This study demonstrated that some metabolic benefits exerted by dietary RS, especially improvements in insulin levels, occur independently of the microbiota and could involve alterations in the bile acid cycle and adipose tissue immune modulation. This work also sets a precedent for future mechanistic studies aimed at establishing the causative role of the gut microbiota in mediating the benefits of bioactive compounds and functional foods. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40168-017-0230-5) contains supplementary material, which is available to authorized users. BioMed Central 2017-02-07 /pmc/articles/PMC5294823/ /pubmed/28166818 http://dx.doi.org/10.1186/s40168-017-0230-5 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Bindels, Laure B.
Segura Munoz, Rafael R.
Gomes-Neto, João Carlos
Mutemberezi, Valentin
Martínez, Inés
Salazar, Nuria
Cody, Elizabeth A.
Quintero-Villegas, Maria I.
Kittana, Hatem
de los Reyes-Gavilán, Clara G
Schmaltz, Robert J.
Muccioli, Giulio G.
Walter, Jens
Ramer-Tait, Amanda E.
Resistant starch can improve insulin sensitivity independently of the gut microbiota
title Resistant starch can improve insulin sensitivity independently of the gut microbiota
title_full Resistant starch can improve insulin sensitivity independently of the gut microbiota
title_fullStr Resistant starch can improve insulin sensitivity independently of the gut microbiota
title_full_unstemmed Resistant starch can improve insulin sensitivity independently of the gut microbiota
title_short Resistant starch can improve insulin sensitivity independently of the gut microbiota
title_sort resistant starch can improve insulin sensitivity independently of the gut microbiota
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294823/
https://www.ncbi.nlm.nih.gov/pubmed/28166818
http://dx.doi.org/10.1186/s40168-017-0230-5
work_keys_str_mv AT bindelslaureb resistantstarchcanimproveinsulinsensitivityindependentlyofthegutmicrobiota
AT seguramunozrafaelr resistantstarchcanimproveinsulinsensitivityindependentlyofthegutmicrobiota
AT gomesnetojoaocarlos resistantstarchcanimproveinsulinsensitivityindependentlyofthegutmicrobiota
AT mutemberezivalentin resistantstarchcanimproveinsulinsensitivityindependentlyofthegutmicrobiota
AT martinezines resistantstarchcanimproveinsulinsensitivityindependentlyofthegutmicrobiota
AT salazarnuria resistantstarchcanimproveinsulinsensitivityindependentlyofthegutmicrobiota
AT codyelizabetha resistantstarchcanimproveinsulinsensitivityindependentlyofthegutmicrobiota
AT quinterovillegasmariai resistantstarchcanimproveinsulinsensitivityindependentlyofthegutmicrobiota
AT kittanahatem resistantstarchcanimproveinsulinsensitivityindependentlyofthegutmicrobiota
AT delosreyesgavilanclarag resistantstarchcanimproveinsulinsensitivityindependentlyofthegutmicrobiota
AT schmaltzrobertj resistantstarchcanimproveinsulinsensitivityindependentlyofthegutmicrobiota
AT muccioligiuliog resistantstarchcanimproveinsulinsensitivityindependentlyofthegutmicrobiota
AT walterjens resistantstarchcanimproveinsulinsensitivityindependentlyofthegutmicrobiota
AT ramertaitamandae resistantstarchcanimproveinsulinsensitivityindependentlyofthegutmicrobiota